Related Experiment Video
Updated: Mar 25, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
[The NLRP3 inflammasome: Physiopathology and therapeutic application]
Thomas Gicquel1, Sacha Robert2, Tatiana Victoni2
1CHU de Rennes, laboratoire de toxicologie biologique et médicolégale, 35033 Rennes, France; Université Rennes 1, faculté de pharmacie, 35043 Rennes, France; Inserm, UMR991 « foie, métabolismes et cancer », 35043 Rennes, France.
Abstract:
The innate immune system constitutes the first line of host defense against pathogens. "Nonself", such as exogenous particles or pathogens, triggers an inflammatory response. Inflammasomes are molecular platforms activated upon cellular infection or stress that trigger the maturation of proinflammatory cytokines such as IL-1β. Activation of the NLRP3 inflammasome pathway, the most extensively studied, appears to be the corner stone of many inflammatory diseases, including Crohn's disease, rheumatoid arthritis and gout. Cryopyrine-associated periodic syndromes (CAPS) are NLRP3 inflammasome-associated diseases. Canakinumab (Ilaris(®)) is the only drug approved for CAPS treatment in France. Targeted therapy against NLRP3 inflammasome and IL-1β might be the new anti-inflammatory drugs.
Related Concept Videos
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

